The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has doubled in the past ten years and is bound to continue to increase. Since the first of these devices was approved in 1994, the technology has changed tremendously, and so has the medical and surgical management...
Main Authors: | Cecilia Berardi, Claudio A. Bravo, Song Li, Maziar Khorsandi, Jeffrey E. Keenan, Jonathan Auld, Sunny Rockom, Jennifer A. Beckman, Claudius Mahr |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/7/2022 |
Similar Items
-
Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3
by: Madina R. Zhalbinova, et al.
Published: (2023-11-01) -
Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
by: Lieke Numan, et al.
Published: (2023-06-01) -
Propensity score‐based analysis of long‐term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support
by: Lieke Numan, et al.
Published: (2021-04-01) -
Validation of non‐invasive ramp testing for HeartMate 3
by: Emil Najjar, et al.
Published: (2020-04-01) -
Comparing short‐term outcome after implantation of the HeartWare® HVAD® and the Abbott® HeartMate 3®
by: Rene Schramm, et al.
Published: (2020-06-01)